Skip to main content
. 2020 Aug 20;11(8):663. doi: 10.1038/s41419-020-02907-x

Fig. 1. Cancer stem cell markers (CSCs) are upregulated in HPV-negative/Nrf2 overexpressing HNSCC tumors.

Fig. 1

a CD44, CD133, EpCAM, and CD49f were compared between Nrf2-high and -low groups using the TCGA dataset. Ratios were calculated by dividing the mRNA expression of the Nrf2-high group by that of the Nrf2-low group. b Nrf2 expression was compared between HPV(+) and HPV(−) group using our own dataset (n = 100). Ratio was calculated by dividing the expression intensity of the HPV(+) group by that of the HPV(−) group. c CSCs expression compared between HPV(+) and HPV(−) group. Ratio was calculated by dividing the expression intensity of the HPV(+) group by that of the HPV(−) group. d Expression of CSCs was compared between Nrf2-high and Nrf2-low group. Ratios were calculated by dividing the expression intensity of the Nrf2-high group by that of the Nrf2-low group. e Cancer stem markers were compared between HNSCC and matched normal tissues. Ratio was calculated by dividing the mRNA expression of the tumor sample by that of the matched normal samples. In all cases, whiskers indicate the maximum and the minimum values. p-values were calculated using Student’s t test.